Structure Database (LMSD)

LM_ID Common Name Systematic Name Main Class Sub Class Mass Formula
LMSP0502AF08 - Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1730.02 C84H151N3O33
LMSP0502BE08 - GalNAcalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1730.02 C84H151N3O33
LMSP0502BG08 - Galbeta1-4GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1730.02 C84H151N3O33
LMSP0502BL08 - GalNAcbeta1-3(Galbeta1-3GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gala1-4Galb1-4Glc- (Globo series) [SP0502] 1730.02 C84H151N3O33
LMSP0503AD08 - Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcb1-4Galb1-4Glc- (Ganglio series) [SP0503] 1730.02 C84H151N3O33
LMSP0503AM08 - GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcb1-4Galb1-4Glc- (Ganglio series) [SP0503] 1730.02 C84H151N3O33
LMSP0503AF08 - Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcb1-4Galb1-4Glc- (Ganglio series) [SP0503] 1730.02 C84H151N3O33
LMSP0504BR08 VI3(Galb 1-4GlcNAcb )-Lc4Cer(d18:1/26:1(17Z)) Galbeta1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series) [SP0504] 1730.02 C84H151N3O33
LMSP0504AL08 - Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-3GlcNAcb1-3Galb1-4Glc- (Lacto series) [SP0504] 1730.02 C84H151N3O33
LMSP0505CB08 IV3Gala -nLc4Cer(d18:1/26:1(17Z)) Galalpha1-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0505EL08 IV 3-nLcOse4(d18:1/26:1(17Z)) GalNAcbeta1-3Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0505AL08 nLc6Cer(d18:1/26:1(17Z)) Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0505CF08 - Galbeta1-4GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0505EJ08 - Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0505BG08 - Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series) [SP0505] 1730.02 C84H151N3O33
LMSP0506AK08 - GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gala1-3Galb1-4Glc- (Isoglobo series) [SP0506] 1730.02 C84H151N3O33
LMSP0506AM08 - Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Gala1-3Galb1-4Glc- (Isoglobo series) [SP0506] 1730.02 C84H151N3O33
Total of 17 Records

Download LMSD record summary for Hex(4)-HexNAc(2)-Cer 44:2;O2